Highest-Volume Intravitreal Injection (Anti-VEGF) Surgeons in New Jersey (2026 update)

105 New Jersey providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in 2024. The top 10 by case volume are below — the full ranked list, CSV export and competitor-payment intel are available with a DocVol subscription ($199/mo, cancel anytime).

Database refreshed July 2026Live NPPES registryⓘ sources
#SurgeonLocationMedicare cases (2024)
1Ronald Sachs, MDCedar Knolls, NJ3,399
2Mohammedyusuf Hajee, M.D.Toms River, NJ2,557
3Robert Barone, MDNewton, NJ2,513
4Mark Friedberg, M.D.Red Bank, NJ2,435
5Lee Angioletti, M.D.Bloomfield, NJ2,262
6Sumit Shah, M.D.New Brunswick, NJ2,170
7Howard Fine, MD MHSCNew Brunswick, NJ2,154
8Jonathan Barofsky, M.D.Lakewood, NJ2,150
9Vinod Voleti, M.D.Morristown, NJ2,083
10Darmakusuma Ie, M.D.Lawrenceville, NJ2,080

95 more New Jersey surgeons in the full list

Plus: who already pays them (Stryker? Medtronic? Arthrex?), CSV export for your CRM, and every other state and procedure.

Search the full database

Frequently asked questions

How many surgeons perform Intravitreal Injection (Anti-VEGF) in New Jersey?
105 New Jersey providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in CY2024. CMS suppresses providers with 10 or fewer Medicare patients, so the true count is somewhat higher.
Where does this data come from?
CMS Medicare Physician & Other Practitioners (fee-for-service Part B claims, CY2024, released May 2026) and CMS Open Payments. Both are official U.S. federal datasets.
Does this include all of a surgeon's cases?
No — it covers traditional Medicare only (no Medicare Advantage, commercial, or Medicaid claims). Absolute volumes undercount total practice, but the ranking of high- vs low-volume surgeons is a strong targeting signal.

Related Retina rankings in New Jersey